(Hypertension. 1996;27:649-652.)
© 1996 American Heart Association, Inc.
Articles |
From the Hypertension and Vascular Research Division, Department of Internal Medicine and Heart and Vascular Institute, Henry Ford Hospital, Detroit, Mich.
Correspondence to YiLin Ren, MD, Hypertension and Vascular Research Division, Henry Ford Hospital, 2799 W Grand Blvd, Detroit, MI 48202.
| Abstract |
|---|
|
|
|---|
Key Words: arterioles tubuloglomerular feedback furosemide rabbit hemodynamics
| Introduction |
|---|
|
|
|---|
To study the interactions between Ang II and macula densa control of glomerular hemodynamics directly, we performed in vitro microperfusion of both the AA and attached macula densa. We examined (1) whether NaCl concentration at the macula densa influences the vasoconstrictor action of Ang II on the AA and (2) whether adding furosemide (which blocks Na+, K+, Cl- cotransport) to the macula densa perfusate alters Ang II action in the AA.
| Methods |
|---|
|
|
|---|
|
The bath consisted of 100 µL MEM containing 0.15% BSA and was exchanged continuously at a rate of 1 mL/min. Microdissection and cannulation were completed within 90 minutes at 8°C, after which the bath was gradually warmed to 37°C for the rest of the experiment. Once the temperature was stable, a 30-minute equilibration period was allowed before any measurements were taken. Images were displayed at magnifications up to x1980 and recorded with a Sony video system consisting of a camera (DXC-755), monitor (PVM1942), and video recorder (EDV-9500). The diameter of the distal AA was measured with an image-analysis system (Fryer).
Experimental Protocols
AA Responses to Ang II With
Various NaCl Concentrations at the
Macula Densa
While AAs were perfused at 60 mm Hg, the macula densa was
perfused with either low NaCl (Na+, 26 mEq/L;
Cl-, 7 mEq/L; n=7) or high NaCl
(Na+, 84 mEq/L; Cl-, 65
mEq/L; n=7) or was left unperfused with the tubular segments cannulated
(n=8). After a 30-minute equilibration period, increasing doses of Ang
II (1 pmol/L to 1 nmol/L) were added to the bath, and the AA was
observed for 5 minutes at each dose. Since we found that the action of
Ang II on the AA was enhanced by high NaCl at the macula densa, we also
examined the effect of another vasoconstrictor,
norepinephrine (1 nmol/L to 1 µmol/L added to the
bath).9 10
Effect of Furosemide at
the Macula Densa on AA Constriction Induced
by Ang II
We examined whether increased Ang II action with high NaCl
at
the macula densa is linked to active transport. Furosemide was added to
low- and high-NaCl macula densa perfusates at 10 µmol/L, and
Ang II action was examined as described above.
Effect of
Ang II Action on AAs Preconstricted With
Norepinephrine
Since increasing NaCl concentration at the macula densa
constricts AAs by 10% to 20%,9 10 we next examined
whether augmentation of Ang II action is due to higher basal AA tone.
While tubular segments containing the macula densa were cannulated but
left unperfused, AAs were perfused with norepinephrine (200
nmol/L) to decrease luminal diameter by approximately 20%, and the
effect of Ang II was examined 10 minutes later.
Statistics
Values are expressed as mean±SEM. A paired
t test
was used to examine whether the diameter at a given concentration was
different from the control value. ANCOVA was used to examine whether
dose-response curves differed between groups, and a two-sample
t test was used to examine whether the change in diameter at
a given concentration differed between groups. A value of
P<.013 was considered significant because of multiple
comparisons.
| Results |
|---|
|
|
|---|
|
|
|
Effect of Furosemide at the Macula Densa on AA Constriction Induced
by Ang II
When the macula densa was perfused with a low-NaCl solution
containing furosemide, the basal luminal diameter of AAs was 21.0±1.0
µm (n=7), whereas it was 19.1±1.2 µm (n=7) for
high NaCl plus
furosemide. In the presence of furosemide, Ang IIinduced constriction
of AAs no longer differed whether the macula densa was perfused with
low or high NaCl (Fig 5
). Dose-response curves were
similar to those obtained when the macula densa was not perfused or was
perfused with low NaCl.
|
Effect of Ang II Action on AAs Preconstricted With
Norepinephrine
Pretreatment with norepinephrine reduced basal
diameter by 19%, from 22.9±0.8 to 18.7±1.1 µm (n=6).
However, it
did not affect the vasoconstrictor action of Ang II (Fig 6
).
|
| Discussion |
|---|
|
|
|---|
It has been reported that there are significant interactions between Ang II and TGF in the control of glomerular hemodynamics. On the one hand, micropuncture studies have examined changes in single-nephron GFR or stop-flow pressure when NaCl concentration at the macula densa was varied while Ang II was maintained at a given level. These studies showed that in normal rats, Ang II infused either systemically or directly into the peritubular capillaries enhances TGF sensitivity, while blocking Ang II action with either ACE inhibitors or receptor antagonists attenuates TGF response.2 3 4 5 7 In addition, the reduced TGF sensitivity associated with ACE inhibition can be partially reversed by infusion of Ang II.2 6 Taken together, these results demonstrate that Ang II can enhance TGF response. On the other hand, there is little information as to whether the level of the TGF signal can modulate the vasoconstrictor action of Ang II in the renal microcirculation. In early studies, Hall et al11 and Hall and Granger12 reported that intravenous Ang II increased calculated resistance of both the AA and efferent arteriole in dogs treated with ACE inhibitors, while blocking TGF with ureteral occlusion abolished increased AA resistance without affecting the increase in efferent arteriole resistance. In contrast, norepinephrine action was well preserved even after ureteral occlusion. More recently, Ikenaga et al13 reported that in juxtamedullary nephrons perfused in vitro, AA constriction induced by Ang II was significantly attenuated either by blockade of TGF with furosemide or interruption of flow to the macula densa. Here, we provide direct evidence that vasoconstrictor action of Ang II in the AA is regulated by NaCl concentration at the macula densa and hence activity of TGF. Our results are fully in accord with previous studies, suggesting an important interaction between Ang II and macula densa control of glomerular hemodynamics.
Although the mechanism of interaction is not clear from the present study, it does not seem to be due to elevated AA tone induced by high NaCl at the macula densa but rather appears to involve tubular transport at the macula densa. It may be that Ang II increases tubular transport at the macula densa, thereby elevating levels of the vasoconstrictor signal (as yet undefined) sent from the macula densa to the AA. It is also possible that Ang II and the vasoconstrictor signal interact at the level of the AA in a synergistic manner. In this regard, it is interesting to note that Ang II and adenosine may enhance each other's action in the AA,14 and adenosine seems to play an important role in AA constriction induced by TGF.15 16 17
The interaction between Ang II and macula densa control of AA resistance may play an important role in various physiological and pathological conditions.12 18 Under physiological conditions, the activity of the renin-angiotensin system seems to be associated mainly with sodium balances. Despite the potent vasoconstrictor action of Ang II, changes in sodium intake usually cause little change in the GFR.19 Such stability may be due to a complex interplay of various renal paracrine hormones20 21 and well-integrated actions of Ang II on both tubules and the AA, which are controlled by NaCl concentration at the macula densa. For instance, during low NaCl intake, increased Ang II would stimulate proximal tubular reabsorption, leading to decreased NaCl delivery to the macula densa (and hence decreased NaCl concentration at the macula densa). Since TGF response is extremely sensitive to changes in NaCl concentration at the macula densa,17 22 it is conceivable that even a small change in NaCl would lessen Ang IIinduced constriction of the AA, thereby maintaining the GFR. Thus, fine-tuning of Ang II action on the AA by NaCl concentration at the macula densa may serve as a basis for the stability of the GFR and hence homeostasis of body fluid and electrolytes despite daily variations in sodium intake.
| Selected Abbreviations and Acronyms |
|---|
|
| Acknowledgments |
|---|
| References |
|---|
|
|
|---|
2. Ploth DW, Roy RN. Renin-angiotensin influences on tubuloglomerular feedback activity in the rat. Kidney Int. 1982;22(suppl 12):114-121.
3. Ploth DW, Rudolph J, LaGrange R, Navar LG. Tubuloglomerular feedback and single nephron function after converting enzyme inhibition in the rat. J Clin Invest. 1979;64:1325-1335.
4. Schnermann J, Briggs J. Role of the renin-angiotensin system in tubuloglomerular feedback. Fed Proc. 1986;45:1426-1430. [Medline] [Order article via Infotrieve]
5. Stowe N, Schnermann J, Hermle M. Feedback regulation of nephron filtration rate during pharmacologic interference with the renin-angiotensin and adrenergic systems in rats. Kidney Int. 1979;15:473-486. [Medline] [Order article via Infotrieve]
6. Navar LG, Carmines PK, Huang WC, Mitchell KD. The tubular effects of angiotensin II. Kidney Int. 1987;31(suppl 20):81-88.
7.
Mitchell KD, Navar LG. Enhanced
tubuloglomerular feedback during peritubular
infusions of angiotensin I and II. Am J
Physiol. 1988;255:F383-F390.
8. Ito S, Johnson CS, Carretero OA. Modulation of angiotensin II-induced vasoconstriction by endothelium-derived relaxing factor in the isolated microperfused rabbit afferent arteriole. J Clin Invest. 1991;87:1656-1663.
9. Ito S, Carretero OA. An in vitro approach to the study of macula densa-mediated glomerular hemodynamics. Kidney Int. 1990;38:1206-1210. [Medline] [Order article via Infotrieve]
10. Ito S, Ren Y. Evidence for the role of nitric oxide in macula densa control of glomerular hemodynamics. J Clin Invest. 1993;92:1093-1098.
11. Hall JE, Guyton AC, Jackson TE, Coleman TG, Lohmeier TE, Trippodo NC. Control of glomerular filtration rate by renin-angiotensin system. Am J Physiol. 1977;233:F366-F372.
12. Hall JE, Granger JP. Renal hemodynamic actions of angiotensin II: interaction with tubuloglomerular feedback. Am J Physiol. 1983;245:R166-R173.
13. Ikenaga H, Fallet RW, Carmines PK. Agonist-specific impact of tubuloglomerular feedback on afferent arteriolar vasoconstrictor responses. FASEB J. 1995;1:1740. Abstract.
14.
Weihprecht H, Lorenz JN, Briggs JP, Schnermann
J. Synergistic effects of angiotensin and
adenosine in the renal microvasculature. Am J
Physiol. 1994;266:F227-F239.
15. Osswald H, Hermes HH, Nabakowski G. Role of adenosine in signal transmission of tubuloglomerular feedback. Kidney Int. 1982;22(suppl 12):S136-S142.
16.
Schnermann J, Weihprecht H, Briggs JP.
Inhibition of tubuloglomerular feedback during
adenosine1 receptor blockade. Am J
Physiol. 1990;258:F553-F561.
17. Ren Y, Ito S. Adenosine (Ado) modulates macula densa (MD) control of afferent arteriolar (AA) resistance. J Am Soc Nephrol. 1994;5:610. Abstract.
18. Navar LG, Saccomani G, Mitchell KD. Synergistic intrarenal actions of angiotensin on tubular reabsorption and renal hemodynamics. Am J Hypertens. 1991;4:90-96. [Medline] [Order article via Infotrieve]
19.
Campese VM. Salt sensitivity in hypertension:
renal and cardiovascular implications.
Hypertension. 1994;23:531-550.
20.
Blasingham MC, Nasjletti A. Differential renal
effects of cyclooxygenase inhibition in
sodium-replete and sodium-deprived dog. Am J
Physiol. 1980;239:F360-F365.
21. Nasjletti A, Malik KU. The renal kallikrein-kinin and prostaglandin systems interaction. Annu Rev Physiol. 1981;43:597-609. [Medline] [Order article via Infotrieve]
22.
Chou C, Marsh DJ. Measurement of flow rate in
rat proximal tubules with a nonobstructing optical method.
Am J Physiol. 1987;253:F366-F371.
This article has been cited by other articles:
![]() |
Y. Ren, M. A. D'Ambrosio, H. Wang, R. Liu, J. L. Garvin, and O. A. Carretero Heme oxygenase metabolites inhibit tubuloglomerular feedback (TGF) Am J Physiol Renal Physiol, October 1, 2008; 295(4): F1207 - F1212. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. M. Sorensen, P. P. Leyssac, M. Salomonsson, O. Skott, and N.-H. Holstein-Rathlou ANG II-induced downregulation of RBF after a prolonged reduction of renal perfusion pressure is due to pre- and postglomerular constriction Am J Physiol Regulatory Integrative Comp Physiol, May 1, 2004; 286(5): R865 - R873. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Ren, O. A. Carretero, and J. L. Garvin Mechanism by Which Superoxide Potentiates Tubuloglomerular Feedback Hypertension, February 1, 2002; 39(2): 624 - 628. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. B. Hansen, B. L. Jensen, and O. Skott Chloride Regulates Afferent Arteriolar Contraction in Response to Depolarization Hypertension, December 1, 1998; 32(6): 1066 - 1070. [Abstract] [Full Text] [PDF] |
||||
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
Hypertension Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 1996 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |